SCHEMBL7146530

SCHEMBL7146530

CCCOCCNC1CCCN([S+]([O-])c2ccc(CNC(=O)c3ccc(Cl)cc3)s2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAPK9 P45984 1/20 0.34
MAPK10 P53779 1/20 0.34
DDR1 Q08345 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM3 P20309 1/20 0.34
CXCR4 P61073 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NAMPT P43490 3/20 0.33
FOXM1 Q08050 1/20 0.33
CCR2 P41597 1/20 0.33
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6021596 0.85 ALDH1A1 (0.41) KDM4EALDH1A1SMN1; SMN2MAPK9MAPK10
SCHEMBL7138046 0.82 KDM4E (0.38) KDM4EALDH1A1SMN1; SMN2MAPK9MAPK10
SCHEMBL7139566 0.81 KDM4E (0.42) KDM4EALDH1A1SMN1; SMN2MAPK9MAPK10
SCHEMBL7142563 0.81 TP53 (0.44) KDM4EALDH1A1SMN1; SMN2LMNATP53
SCHEMBL3479853 0.81 MAPK9 (0.52) KDM4EALDH1A1SMN1; SMN2MAPK9MAPK10
SCHEMBL3479923 0.79 MAPK9 (0.55) KDM4EALDH1A1SMN1; SMN2MAPK9MAPK10
SCHEMBL7149127 0.78 MEN1 (0.52) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6021542 0.77 CXCR3 (0.42) KDM4EALDH1A1SMN1; SMN2MAPK9MAPK10
SCHEMBL7145105 0.76 CHRM1 (0.44) ALDH1A1
SCHEMBL7139305 0.76 MAPK14 (0.43) ALDH1A1SMN1; SMN2MAPK9MAPK10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322642-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES Applied Research Systems ARS Holding N.V. (AN) 2003-07-02 EP claimed
WO-2002026733-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2002-04-04 WO claimed
EP-1322642-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES Applied Research Systems ARS Holding N.V. (AN) 2003-07-02 EP disclosed
WO-2002026733-A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2002-04-04 WO disclosed